Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03154021 · ClinicalTrials.gov registry record · Phase 1
Next Science Antimicrobial Mouth Rinse Study
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 118
- Enrollment target
NCT03154021: Completed Phase 1 study, sponsored by University of Florida.
NCT03154021 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 118 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03154021, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 118 participants
- Enrollment target
Study Summary
To assess the effect of a test antimicrobial oral rinse from Next Science on the prevention of oral biofilm formation and thereby preventing gingivitis by monitoring the oral microbial flora and measuring gingival inflammation and bleeding.
Primary Outcome
Complete oral exam with charting of pocket depths
Interventions
- COMBINATION_PRODUCT Next Science OTC Oral Rinse with Essential Oils
- COMBINATION_PRODUCT OTC Oral Rinse Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2017-08-28 |
| Est. Completion | 2018-05-15 |
| Phase | Phase 1 |
What the finished NCT03154021 record still lists
NCT03154021 is an interventional study that assigns participants to a tested intervention. The registered 118 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (97% higher).
The record links to 0 conditions, and to 2 interventions - of which Next Science OTC Oral Rinse with Essential Oils is the first listed.
NCT03154021 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03154021 about?
NCT03154021 is a clinical study titled "Next Science Antimicrobial Mouth Rinse Study". To assess the effect of a test antimicrobial oral rinse from Next Science on the prevention of oral biofilm formation and thereby preventing gingivitis by monitoring the oral microbial flora and measuring gingival inflammation and bleeding.
What is the current status of trial NCT03154021?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 118 participants. The study started on 2017-08-28. Estimated completion is 2018-05-15.
What interventions are being tested in trial NCT03154021?
The interventions under investigation include: Next Science OTC Oral Rinse with Essential Oils (COMBINATION_PRODUCT), OTC Oral Rinse Control (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT03154021?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03154021's enrollment target sits among peer trials
118 499th of 2000 higher than 1,502 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03821623 · 118 participants · Phase 2
Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
- NCT04040959 · 118 participants · Phase 2
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
- NCT04696029 · 118 participants · Phase 2
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- NCT05223192 · 118 participants · NA
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI